141 related articles for article (PubMed ID: 17433856)
1. Editorial comment on: Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen.
von der Maase H
Eur Urol; 2007 Oct; 52(4):1122. PubMed ID: 17433856
[No Abstract] [Full Text] [Related]
2. Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen.
Kouno T; Ando M; Yonemori K; Matsumoto K; Shimizu C; Katsumata N; Komiyama M; Okajima E; Matsuoka N; Fujimoto H; Fujiwara Y
Eur Urol; 2007 Oct; 52(4):1115-22. PubMed ID: 17433855
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics of paclitaxel and carboplatin in a hemodialysis patient with metastatic urothelial carcinoma--a case report].
Furuya Y; Takihana Y; Araki I; Tanabe N; Takeda M
Gan To Kagaku Ryoho; 2003 Jul; 30(7):1017-20. PubMed ID: 12894722
[TBL] [Abstract][Full Text] [Related]
4. Comparison of outcomes for elderly patients treated with weekly paclitaxel in combination with carboplatin versus the standard 3-weekly paclitaxel and carboplatin for advanced nonsmall cell lung cancer.
Ramalingam S; Perry MC; La Rocca RV; Rinaldi D; Gable PS; Tester WJ; Belani CP
Cancer; 2008 Aug; 113(3):542-6. PubMed ID: 18512224
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy for advanced urothelial cancer patients with a combination of low-dose consecutive cisplatin and etoposide].
Hashimoto H; Tokumitsu M; Morikawa M; Numata A; Yachiku S; Iuchi H; Yamauchi K
Gan To Kagaku Ryoho; 1996 Jun; 23(7):941-4. PubMed ID: 8678548
[No Abstract] [Full Text] [Related]
6. Chemotherapy with methotrexate, vinblastine, epirubicin and carboplatin (Carbo-MVE) in transitional cell urothelial cancer. A Hellenic Co-Operative Oncology Group study.
Skarlos DV; Aravantinos G; Linardou E; Kostakopoulos CA; Kastriotis I; Christodoulou C; Picramenos D; Giannakakis T; Dimopoulos K; Fountzilas G
Eur Urol; 1997; 31(4):420-7. PubMed ID: 9187901
[TBL] [Abstract][Full Text] [Related]
7. [Clinical study of combination chemotherapy of methotrexate, epirubicin and nedaplatin (MEN) in patients with advanced urothelial carcinoma].
Hattori Y; Takizawa A; Kishida T; Kakizoe M; Fujikawa N; Teranishi J; Kondo K; Saito K; Noguchi K; Nakaigawa N; Kubota Y
Gan To Kagaku Ryoho; 2007 May; 34(5):739-43. PubMed ID: 17496448
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel and carboplatin in bladder cancer: recent developments.
Vaughn DJ
Eur J Cancer; 2000 Jul; 36 Suppl 2():7-12. PubMed ID: 10908842
[TBL] [Abstract][Full Text] [Related]
9. The combination of monthly carboplatin and weekly paclitaxel is highly active for the treatment of recurrent ovarian cancer.
Hoekstra AV; Hurteau JA; Kirschner CV; Rodriguez GC
Gynecol Oncol; 2009 Dec; 115(3):377-81. PubMed ID: 19800107
[TBL] [Abstract][Full Text] [Related]
10. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
Azuma K; Sasada T; Kawahara A; Takamori S; Hattori S; Ikeda J; Itoh K; Yamada A; Kage M; Kuwano M; Aizawa H
Lung Cancer; 2009 Jun; 64(3):326-33. PubMed ID: 18977553
[TBL] [Abstract][Full Text] [Related]
11. [Feasibility and change in the level of blood paclitaxel concentration after paclitaxel therapy for a hemodialysis patient with cisplatin resistant metastatic transitional cell cancer].
Nomata K; Sagara Y; Toubu S; Hakariya T; Tsuda S; Noguchi M; Eguchi J; Kanetaka H
Gan To Kagaku Ryoho; 2002 Jul; 29(7):1247-50. PubMed ID: 12146008
[TBL] [Abstract][Full Text] [Related]
12. Phase III trial comparing carboplatin, paclitaxel, and bexarotene with carboplatin and paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT II.
Blumenschein GR; Khuri FR; von Pawel J; Gatzemeier U; Miller WH; Jotte RM; Le Treut J; Sun SL; Zhang JK; Dziewanowska ZE; Negro-Vilar A
J Clin Oncol; 2008 Apr; 26(11):1879-85. PubMed ID: 18398153
[TBL] [Abstract][Full Text] [Related]
13. Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer.
Belani CP; Ramalingam S; Perry MC; LaRocca RV; Rinaldi D; Gable PS; Tester WJ
J Clin Oncol; 2008 Jan; 26(3):468-73. PubMed ID: 18202422
[TBL] [Abstract][Full Text] [Related]
14. The outcome of patients with advanced pure squamous or mixed squamous and transitional urothelial carcinomas following platinum-based chemotherapy.
Kastritis E; Dimopoulos MA; Antoniou N; Deliveliotis C; Chrisofos M; Skolarikos A; Gika D; Bamias A
Anticancer Res; 2006; 26(5B):3865-9. PubMed ID: 17094415
[TBL] [Abstract][Full Text] [Related]
15. A Case of Plasmacytoid Variant of Bladder Cancer With a Single Penile Metastasis and a Complete Response to Carboplatin-Based Chemotherapy and Review of the Literature.
Messina C; Zanardi E; Dellepiane C; Tomasello L; Colecchia M; Ravetti GL; Boccardo F; Spina B
Clin Genitourin Cancer; 2016 Feb; 14(1):e139-42. PubMed ID: 26627132
[No Abstract] [Full Text] [Related]
16. Weekly paclitaxel and gemcitabine in advanced transitional-cell carcinoma of the urothelium: a Phase II Hoosier Oncology Group Study.
Montie JE
J Urol; 2005 Nov; 174(5):1784. PubMed ID: 16217286
[No Abstract] [Full Text] [Related]
17. Bladder cancer: management of advanced disease.
Chong CD
Tex Med; 1987 Feb; 83(2):51-4. PubMed ID: 3824246
[No Abstract] [Full Text] [Related]
18. Chemotherapy of advanced bladder cancer.
Hall RR; Roberts JT
Prog Clin Biol Res; 1989; 303():525-31. PubMed ID: 2675009
[No Abstract] [Full Text] [Related]
19. Phase II study of 24-hour infusion of paclitaxel (Intaxel) with carboplatin in advanced non-small cell lung cancer.
Charoentum C; Thongprasert S; Chewasakulyong B
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1603-7. PubMed ID: 17940374
[TBL] [Abstract][Full Text] [Related]
20. [Chemotherapy of urothelial tumors of the bladder].
Culine S; Guastalla JP; Théodore C; Droz JP
Bull Cancer Radiother; 1994; 81(4):303-11. PubMed ID: 7702915
[No Abstract] [Full Text] [Related]
[Next] [New Search]
